OASGX
Price
$11.95
Change
-$0.02 (-0.17%)
Updated
Aug 15 closing price
Net Assets
724.08M
WCMLX
Price
$13.18
Change
-$0.08 (-0.60%)
Updated
Aug 15 closing price
Net Assets
44.09M
Interact to see
Advertisement

OASGX vs WCMLX

Header iconOASGX vs WCMLX Comparison
Open Charts OASGX vs WCMLXBanner chart's image
Optimum Small-Mid Cap Growth A
Price$11.95
Change-$0.02 (-0.17%)
VolumeN/A
Net Assets724.08M
WCM Small Cap Growth Institutional
Price$13.18
Change-$0.08 (-0.60%)
VolumeN/A
Net Assets44.09M
OASGX vs WCMLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OASGX vs. WCMLX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OASGX is a Buy and WCMLX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OASGX has more cash in the bank: 724M vs. WCMLX (44.1M). OASGX (0.00) and WCMLX (0.00) have matching dividends . OASGX was incepted earlier than WCMLX: OASGX (22 years) vs WCMLX (6 years). WCMLX (1.79) is less costly to investors than OASGX (1.66). OASGX is a more actively managed with annual turnover of: 131.00 vs. WCMLX (83.00). OASGX has a lower initial minimum investment than WCMLX: OASGX (1000) vs WCMLX (100000). OASGX annual gain was more profitable for investors over the last year : 5.85 vs. WCMLX (3.13). WCMLX return over 5 years is better than : 17.47 vs. OASGX (-21.74).
OASGXWCMLXOASGX / WCMLX
Total Expense Ratio1.490.99151%
Annual Report Gross Expense Ratio1.661.7993%
Fund Existence22 years6 years-
Gain YTD1.7022.48868%
Front Load6%N/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets724M44.1M1,642%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.853.13187%
Returns for 3 years2.939.3831%
Returns for 5 years-21.7417.47-124%
Returns for 10 years-21.74N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXRX1.240.06
+5.08%
Lexicon Pharmaceuticals
ISRL12.700.39
+3.17%
Israel Acquisitions Corp
MESO16.250.39
+2.46%
Mesoblast Limited
SXTP1.320.01
+0.76%
60 Degrees Pharmaceuticals Inc.
EHC120.380.73
+0.61%
Encompass Health Corp